CN108514122A - The preparation method of minerals supplementing preparation - Google Patents
The preparation method of minerals supplementing preparation Download PDFInfo
- Publication number
- CN108514122A CN108514122A CN201810169527.5A CN201810169527A CN108514122A CN 108514122 A CN108514122 A CN 108514122A CN 201810169527 A CN201810169527 A CN 201810169527A CN 108514122 A CN108514122 A CN 108514122A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- minerals
- preparation
- supplementing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 44
- 239000011707 mineral Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 230000001502 supplementing effect Effects 0.000 title claims abstract description 17
- 235000010755 mineral Nutrition 0.000 claims abstract description 43
- 229940088594 vitamin Drugs 0.000 claims abstract description 28
- 229930003231 vitamin Natural products 0.000 claims abstract description 28
- 235000013343 vitamin Nutrition 0.000 claims abstract description 28
- 239000011782 vitamin Substances 0.000 claims abstract description 28
- 239000011669 selenium Substances 0.000 claims abstract description 26
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 25
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 24
- 230000034659 glycolysis Effects 0.000 claims abstract description 18
- 102000008186 Collagen Human genes 0.000 claims abstract description 16
- 108010035532 Collagen Proteins 0.000 claims abstract description 16
- 229920001436 collagen Polymers 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000894006 Bacteria Species 0.000 claims abstract description 11
- 239000011720 vitamin B Substances 0.000 claims abstract description 11
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 10
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 6
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 6
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 6
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 6
- 229940035035 polydextrose Drugs 0.000 claims abstract description 6
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 6
- 239000001259 polydextrose Substances 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 3
- VVYPIVJZLVJPGU-UHFFFAOYSA-L copper;2-aminoacetate Chemical compound [Cu+2].NCC([O-])=O.NCC([O-])=O VVYPIVJZLVJPGU-UHFFFAOYSA-L 0.000 claims abstract description 3
- 229940011405 cupric glycinate Drugs 0.000 claims abstract description 3
- 235000002332 ferrous fumarate Nutrition 0.000 claims abstract description 3
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 3
- 239000011718 vitamin C Substances 0.000 claims abstract description 3
- 229940110280 zinc methionine Drugs 0.000 claims abstract description 3
- CNMFGFBWPBBGKX-SCGRZTRASA-L zinc;(2s)-2-amino-4-methylsulfanylbutanoate Chemical compound [Zn+2].CSCC[C@H](N)C([O-])=O.CSCC[C@H](N)C([O-])=O CNMFGFBWPBBGKX-SCGRZTRASA-L 0.000 claims abstract description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 244000235858 Acetobacter xylinum Species 0.000 claims description 5
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 5
- YSAVZVORKRDODB-UHFFFAOYSA-N Diethyl tartrate Chemical compound CCOC(=O)C(O)C(O)C(=O)OCC YSAVZVORKRDODB-UHFFFAOYSA-N 0.000 claims description 5
- 102000002322 Egg Proteins Human genes 0.000 claims description 5
- 108010000912 Egg Proteins Proteins 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 5
- 229930003779 Vitamin B12 Natural products 0.000 claims description 5
- 235000015278 beef Nutrition 0.000 claims description 5
- 210000003278 egg shell Anatomy 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000003292 glue Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- 229940055726 pantothenic acid Drugs 0.000 claims description 5
- 235000019161 pantothenic acid Nutrition 0.000 claims description 5
- 239000011713 pantothenic acid Substances 0.000 claims description 5
- 235000019834 papain Nutrition 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 244000063299 Bacillus subtilis Species 0.000 claims description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 28
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 21
- 239000011575 calcium Substances 0.000 abstract description 21
- 229910052791 calcium Inorganic materials 0.000 abstract description 21
- 239000004615 ingredient Substances 0.000 abstract description 16
- 229910052742 iron Inorganic materials 0.000 abstract description 14
- 210000000988 bone and bone Anatomy 0.000 abstract description 12
- 239000000126 substance Substances 0.000 abstract description 12
- 238000010521 absorption reaction Methods 0.000 abstract description 11
- 238000009472 formulation Methods 0.000 abstract description 11
- 241000411851 herbal medicine Species 0.000 abstract description 11
- 239000000203 mixture Substances 0.000 abstract description 11
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 11
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 8
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 7
- 208000002177 Cataract Diseases 0.000 abstract description 7
- 239000002956 ash Substances 0.000 abstract description 7
- 230000002265 prevention Effects 0.000 abstract description 7
- 235000002918 Fraxinus excelsior Nutrition 0.000 abstract description 5
- 208000017667 Chronic Disease Diseases 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 abstract 1
- 239000011773 ferrous fumarate Substances 0.000 abstract 1
- 229960000225 ferrous fumarate Drugs 0.000 abstract 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 9
- 239000011574 phosphorus Substances 0.000 description 9
- 229910052698 phosphorus Inorganic materials 0.000 description 9
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 210000003405 ileum Anatomy 0.000 description 5
- 210000001630 jejunum Anatomy 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- -1 phosphate radical Chemical class 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- LGGKLHHIIOOPKS-WCCKRBBISA-N (2s)-2-amino-4-methylsulfanylbutanoic acid;zinc Chemical class [Zn].CSCC[C@H](N)C(O)=O LGGKLHHIIOOPKS-WCCKRBBISA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 241001614291 Anoplistes Species 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical group Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000008114 Selenoproteins Human genes 0.000 description 1
- 108010074686 Selenoproteins Proteins 0.000 description 1
- 206010047612 Vitamin B2 deficiency Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 201000007590 ariboflavinosis Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 238000007833 oxidative deamination reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003617 peroxidasic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 208000004223 riboflavin deficiency Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of preparation methods of minerals supplementing preparation, and ingredient and its parts by weight include:15 ~ 30 parts, 30 ~ 40 parts of dregs of beans, 0.2 ~ 0.5 part of Radix Astragali, 0.1 ~ 0.4 part, 10 ~ 18 parts psoralea corylifolias of folium isatidis, 6 ~ 12 parts of collagens, 1 ~ 3 part of zinc methionine, 1 ~ 3 part of cupric glycinate, 1 ~ 3 part of ferrous fumarate, 1 ~ 3 part of malt selenium, 1 ~ 3 part of polydextrose, 1 ~ 3 part of vitamin B compound and 1 ~ 3 part of vitamin C.Advantageous effect:The present invention is effectively combined the substances such as Chinese herbal medicine effective ingredients, active peptide and vitamin by bacterium enzyme glycolysis, hence it is evident that enhances the dissolubility and absorbability of minerals.Invention formulation can significantly improve absorption of the body to minerals such as calcium, selenium, iron, improve its biological effectiveness, promote formation and the mineralising of bone, increase bone weight and content of ashes, the chronic diseases such as effective prevention of cardiovascular disease, diabetes, cataract.
Description
Technical field
The present invention relates to nutritional supplement arts, the preparation method of specifically a kind of minerals supplementing preparation.
Background technology
Calcium, phosphorus are mainly stored in the form of inorganic salts in animal body, and shared ratio is higher than 7 in the total ash of body
0%, it is a kind of inorganic salts in body at most.Calcium, phosphorus are primarily present in animal skeleton and tooth, general in vivo more than 99%
Calcium and phosphorus more than 80% be all present in the two, only there are minimal amounts in body fluid.For adults, itself can lead to
Cross constantly intake and discharge calcium, phosphorus and both ensure dynamic equilibrium, but cub is often compared due to the calcium needed for growing, phosphorus intake
Discharge rate is more, and normal equilibrium state is kept both to can also make.Animal mainly passes through intestinal absorption calcium, phosphorus, therefore feed
Contained in calcium, phosphorus ratio and its absorb it is closely related, as long as can be combined with calcium, phosphorus to form insoluble substance will be right
The absorption of calcium, phosphorus impacts.
Selenium is known as " king of anti-cancer " in body trace element by scientist.Selenium is glutathione peroxidase (GSH-
Px activated centre), the latter are a kind of important antioxidases, have and remove free radical, protect body from oxidative damage
Effect.The 1/3 of selenium total amount participates in GSH-Px synthesis, and remainder exists in the form of selenoprotein.Selenium has anti-oxidant, raising body
The physiological functions such as immunity, anti-aging, while can also effectively prevention of cardiovascular disease, diabetes, cataract etc., selenium resist
Oxidation contributes to the performance of insulin function, lacks Peroxidative damage caused by selenium in body, it may be possible to which islet function declines
The main reason for subtracting.Nearest medical research shows that the Se content in diabetic's blood is significantly lower than Healthy People, and human body lacks
Selenium is to cause one of pathogenetic inducement of glycosuria, and a series of diabetic symptoms and its complication can be caused to occur.
Vitamin B1 forms phosphorylated thiamine in vivo, and it is anti-to participate in pyruvic acid, the oxidative deamination of alpha Ketoglutarate in glycometabolism
It answers, obstacle occurs for glycometabolism when shortage.Vitamin B1 still maintains heart, nerve and digestive system normal function institute required, dimension
Raw element B1 can cause a variety of neuroinflamations, such as athlete's foot when lacking.Vitamin B2, also known as riboflavin are many enzyme systems of body
The constituent of important prothetic group participates in matter and energy metabolism.It is extra since human body is limited to the storage capability of vitamin B2
It will pass through urine to excrete, therefore Vitamin B2 deficiency is more universal.Vitamin B6 is also known as pyridoxal, is the certain coenzyme of human body
Constituent, participate in a variety of metabolic responses, especially have substantial connection with the metabolism of amino acid.
Polydextrose is called water-soluble dietary fiber, is a kind of food additives with healthcare function.U.S.'s food with
Drug Administration (FDA) and Food and Drug Administration/World Health Organization (FAO/WHO) approved polydextrose are safe
Food additives, and it is included in U.S.'s Food Chemistry product code (FCC).So far having more than 50 a state approvals, it eats as health
Product dispensing uses, and Japanese Health and human services department has confirmed that polydextrose is a kind of food, and China is also included in state food additive,
It is widely used in the numerous foods such as health products, Flour product, meat products, dairy products, beverage.Polydextrose, which has, adjusts blood fat, drop
Low cholesterol and triglycerides, the absorption of reduction sugar amount, promotion mineral absorption, prophylactic treatment constipation, raising immunity etc. are a variety of
Effect.
Invention content
The purpose of the present invention is to provide it is a kind of rich in can minerals such as sorbefacient calcium, selenium, iron mutually minerals
The preparation method of supplementing preparation.Body is high to the absorption rate of various minerals in preparation, life of the minerals in human body
Object validity is good.
To achieve the above object, the technical solution that the present invention takes is:
The preparation method of minerals supplementing preparation, includes the following steps:
1)Weigh 0.1 ~ 0.4 part of 15 ~ 30 parts of egg shell, 30 ~ 40 parts of dregs of beans, 0.2 ~ 0.5 part of Radix Astragali and folium isatidis, ultramicro grinding;
2)10 ~ 15 parts of glucose, 3 ~ 8 parts of beef extract and L- are added in material(+)0.1 ~ 0.3 part of ethyl tartrate, connects
5 ~ 10 parts of bacillus subtilises of kind, 5 ~ 10 parts of acetobacter xylinums, 5 ~ 10 parts of saccharomyces cerevisiaes and 4 ~ 8 parts of papains, bacterium enzyme glycolysis 2
~ 5d, glycolysis temperature are 30 ~ 35 DEG C, and glycolysis pH is 5.0 ~ 7.0, filters to take filtrate;
3)In filtrate be added 10 ~ 18 parts of psoralea corylifolias, 6 ~ 12 parts of collagens, 1 ~ 3 part of zinc methionine, 1 ~ 3 part of cupric glycinate, 1 ~
3 parts of ferrous fumarates, 1 ~ 3 part of malt selenium, 1 ~ 3 part of vitamin B compound and 1 ~ 3 part of vitamin C, after mixing concentrating sterilizing obtain
To minerals supplementing preparation.The present invention is effective by substances such as Chinese herbal medicine effective ingredients, active peptide and vitamins by bacterium enzyme glycolysis
In conjunction with when these ingredients reach the lower end of the small intestines such as ileum and part jejunum, by minerals packets such as calcium, selenium, iron in preparation
It encloses, forms soluble complex.Chinese herbal medicine effective ingredients, active peptide and vitamin etc. in the minerals and invention formulation of enteral
Substance keeps free state without being acted on by phosphate radical, hence it is evident that enhance the dissolving of minerals with very high frequency contact, release
Property and absorbability.It can be seen that invention formulation can significantly improve absorption of the body to minerals such as calcium, selenium, iron, it is improved
Biological effectiveness promotes formation and the mineralising of bone, increases bone weight and content of ashes, effective prevention of cardiovascular disease, sugar
Urinate the chronic diseases such as disease, cataract.
Collagen is specially Isin glue collagen.
Vitamin B compound is:1 ~ 2 part of vitamin B1,1 ~ 2 part of vitamin B2,4 ~ 8 parts of niacin, 3 ~ 6 parts of pantothenic acid, 1 ~ 2 part of dimension
Raw element B6,0.1 ~ 0.2 part of folic acid, 0.001 ~ 0.003 part of vitamin B12.
Compared with the prior art, the advantages of the present invention are as follows:The present invention by bacterium enzyme glycolysis, by Chinese herbal medicine effective ingredients,
The substances such as active peptide and vitamin effectively combine, and when these ingredients reach the lower end of the small intestines such as ileum and part jejunum, will make
The minerals such as calcium, selenium, iron in agent surround, and form soluble complex.Chinese herbal medicine in the minerals and invention formulation of enteral
The substances such as active ingredient, active peptide and vitamin keep free state without by phosphate radical with very high frequency contact, release
Effect, hence it is evident that enhance the dissolubility and absorbability of minerals.It can be seen that invention formulation can significantly improve body to calcium, selenium,
The absorption of the minerals such as iron improves its biological effectiveness, promotes formation and the mineralising of bone, increases bone weight and ash content contains
Amount, the chronic diseases such as effective prevention of cardiovascular disease, diabetes, cataract.
Specific implementation mode
The present invention program is described further below by embodiment:
Embodiment 1:
The preparation method of minerals supplementing preparation, includes the following steps:
1)Weigh 0.3 part of 20 parts of egg shell, 34 parts of dregs of beans, 0.4 part of Radix Astragali and folium isatidis, ultramicro grinding;
2)13 parts of glucose, 4 parts of beef extract and L- are added in material(+)0.2 part of ethyl tartrate is inoculated with 8 portions of withered grass
Bacillus, 6 parts of acetobacter xylinums, 8 parts of saccharomyces cerevisiaes and 6 parts of papains, bacterium enzyme glycolysis 5d, glycolysis temperature are 33 DEG C, ferment
It is 5.5 to solve pH, filters to take filtrate;
3)14 parts of psoralea corylifolias, 10 parts of collagens, 2 parts of zinc methionines, 2 parts of cupric glycinates, 2 parts of fumaric acid Asias are added in filtrate
Iron, 2 parts of malt selenium, 2 parts of vitamin B compounds and 2 parts of vitamin Cs, after mixing concentrating sterilizing obtain minerals supplementing preparation.
The present invention is effectively combined the substances such as Chinese herbal medicine effective ingredients, active peptide and vitamin by bacterium enzyme glycolysis, when these ingredients arrive
Up to the small intestines such as ileum and part jejunum lower end when, the minerals such as calcium, selenium, iron in preparation are surrounded, are formed soluble compound
Object.The substances such as Chinese herbal medicine effective ingredients, active peptide and vitamin are with very high frequency in the minerals and invention formulation of enteral
Contact, release, keep free state without being acted on by phosphate radical, hence it is evident that enhance the dissolubility and absorbability of minerals.Thus
As it can be seen that invention formulation can significantly improve absorption of the body to minerals such as calcium, selenium, iron, its biological effectiveness is improved, is promoted
The formation of bone and mineralising, increase bone weight and content of ashes, and effective prevention of cardiovascular disease, diabetes, cataract etc. are slow
Property disease.
Collagen is specially Isin glue collagen.
Vitamin B compound is:1 part of vitamin B1,1.5 parts of vitamin B2s, 6 parts of niacin, 4 parts of pantothenic acid, 1.5 parts of vitamins
B6,0.15 part of folic acid, 0.002 part of vitamin B12.
Embodiment 2:
The preparation method of minerals supplementing preparation, includes the following steps:
1)Weigh 0.3 part of 27 parts of egg shell, 31 parts of dregs of beans, 0.3 part of Radix Astragali and folium isatidis, ultramicro grinding;
2)14 parts of glucose, 6 parts of beef extract and L- are added in material(+)0.2 part of ethyl tartrate is inoculated with 9 portions of withered grass
Bacillus, 7 parts of acetobacter xylinums, 6 parts of saccharomyces cerevisiaes and 6 parts of papains, bacterium enzyme glycolysis 4d, glycolysis temperature are 33 DEG C, ferment
It is 6.0 to solve pH, filters to take filtrate;
3)13 parts of psoralea corylifolias, 9 parts of collagens, 2 parts of zinc methionines, 1.5 parts of cupric glycinates, 2 parts of fumaric acid are added in filtrate
Ferrous iron, 1.9 parts of malt selenium, 2 parts of vitamin B compounds and 2.6 parts of vitamin Cs, after mixing concentrating sterilizing obtain minerals benefit
Fill preparation.The present invention is effectively combined the substances such as Chinese herbal medicine effective ingredients, active peptide and vitamin, by bacterium enzyme glycolysis when this
When a little ingredients reach the lower end of the small intestines such as ileum and part jejunum, the minerals such as calcium, selenium, iron in preparation are surrounded, formation can
Dissolubility compound.The substances such as Chinese herbal medicine effective ingredients, active peptide and vitamin are with very in the minerals and invention formulation of enteral
High frequency is contacted, is discharged, and keeps free state without being acted on by phosphate radical, hence it is evident that enhance dissolubility and the absorption of minerals
Property.It can be seen that invention formulation can significantly improve absorption of the body to minerals such as calcium, selenium, iron, its biologically effective is improved
Property, promote formation and the mineralising of bone, increases bone weight and content of ashes, it is effective prevention of cardiovascular disease, diabetes, white
The chronic diseases such as cataract or glaucoma.
Collagen is specially Isin glue collagen.
Vitamin B compound is:1.5 parts of vitamin B1s, 1.5 parts of vitamin B2s, 7 parts of niacin, 5 parts of pantothenic acid, 1.9 parts of vitamins
B6,0.11 part of folic acid, 0.002 part of vitamin B12.
Embodiment 3:
The preparation method of minerals supplementing preparation, includes the following steps:
1)Weigh 0.2 part of 27 parts of egg shell, 35 parts of dregs of beans, 0.4 part of Radix Astragali and folium isatidis, ultramicro grinding;
2)13 parts of glucose, 4 parts of beef extract and L- are added in material(+)0.3 part of ethyl tartrate is inoculated with 8 portions of withered grass
Bacillus, 7 parts of acetobacter xylinums, 8 parts of saccharomyces cerevisiaes and 6 parts of papains, bacterium enzyme glycolysis 4d, glycolysis temperature are 33 DEG C, ferment
It is 6.0 to solve pH, filters to take filtrate;
3)16 parts of psoralea corylifolias, 11 parts of collagens, 2 parts of zinc methionines, 2 parts of cupric glycinates, 2 parts of fumaric acid Asias are added in filtrate
Iron, 2 parts of malt selenium, 3 parts of vitamin B compounds and 3 parts of vitamin Cs, after mixing concentrating sterilizing obtain minerals supplementing preparation.
The present invention is effectively combined the substances such as Chinese herbal medicine effective ingredients, active peptide and vitamin by bacterium enzyme glycolysis, when these ingredients arrive
Up to the small intestines such as ileum and part jejunum lower end when, the minerals such as calcium, selenium, iron in preparation are surrounded, are formed soluble compound
Object.The substances such as Chinese herbal medicine effective ingredients, active peptide and vitamin are with very high frequency in the minerals and invention formulation of enteral
Contact, release, keep free state without being acted on by phosphate radical, hence it is evident that enhance the dissolubility and absorbability of minerals.Thus
As it can be seen that invention formulation can significantly improve absorption of the body to minerals such as calcium, selenium, iron, its biological effectiveness is improved, is promoted
The formation of bone and mineralising, increase bone weight and content of ashes, and effective prevention of cardiovascular disease, diabetes, cataract etc. are slow
Property disease.
Collagen is specially Isin glue collagen.
Vitamin B compound is:1.9 parts of vitamin B1s, 1.5 parts of vitamin B2s, 7 parts of niacin, 5 parts of pantothenic acid, 1.5 parts of vitamins
B6,0.15 part of folic acid, 0.003 part of vitamin B12.
Routine operation in the operating procedure of the present invention is well known to those skilled in the art, herein without repeating.
Technical scheme of the present invention is described in detail in embodiment described above, it should be understood that the above is only
For specific embodiments of the present invention, it is not intended to restrict the invention, all any modifications made in the spirit of the present invention,
Supplement or similar fashion replacement etc., should all be included in the protection scope of the present invention.
Claims (4)
1. the preparation method of minerals supplementing preparation, it is characterised in that include the following steps:
1)Weigh 0.1 ~ 0.4 part of 15 ~ 30 parts of egg shell, 30 ~ 40 parts of dregs of beans, 0.2 ~ 0.5 part of Radix Astragali and folium isatidis, ultramicro grinding;
2)10 ~ 15 parts of glucose, 3 ~ 8 parts of beef extract and L- are added in material(+)0.1 ~ 0.3 part of ethyl tartrate, connects
5 ~ 10 parts of bacillus subtilises of kind, 5 ~ 10 parts of acetobacter xylinums, 5 ~ 10 parts of saccharomyces cerevisiaes and 4 ~ 8 parts of papains, bacterium enzyme glycolysis 2
~ 5d, filters to take filtrate;
3)In filtrate be added 10 ~ 18 parts of psoralea corylifolias, 6 ~ 12 parts of collagens, 1 ~ 3 part of zinc methionine, 1 ~ 3 part of cupric glycinate, 1 ~
3 parts of ferrous fumarates, 1 ~ 3 part of malt selenium, 1 ~ 3 part of polydextrose, 1 ~ 3 part of vitamin B compound and 1 ~ 3 part of vitamin C, mixing are equal
Concentrating sterilizing obtains minerals supplementing preparation after even.
2. the preparation method of minerals supplementing preparation according to claim 1, it is characterised in that:The glycolysis temperature is
30 ~ 35 DEG C, glycolysis pH is 5.0 ~ 7.0.
3. the preparation method of minerals supplementing preparation according to claim 1, it is characterised in that:The collagen tool
Body is Isin glue collagen.
4. the preparation method of minerals supplementing preparation according to claim 1, it is characterised in that:The multi-vitamins
B is 1 ~ 2 part of vitamin B1,1 ~ 2 part of vitamin B2,4 ~ 8 parts of niacin, 3 ~ 6 parts of pantothenic acid, 1 ~ 2 part of vitamin B6,0.1 ~ 0.2 part of leaf
Acid, 0.001 ~ 0.003 part of vitamin B12.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810169527.5A CN108514122A (en) | 2018-02-28 | 2018-02-28 | The preparation method of minerals supplementing preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810169527.5A CN108514122A (en) | 2018-02-28 | 2018-02-28 | The preparation method of minerals supplementing preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108514122A true CN108514122A (en) | 2018-09-11 |
Family
ID=63433359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810169527.5A Withdrawn CN108514122A (en) | 2018-02-28 | 2018-02-28 | The preparation method of minerals supplementing preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108514122A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822691A (en) * | 2009-03-04 | 2010-09-08 | 刘冬妮 | Eggshell calcium |
CN103734507A (en) * | 2013-12-12 | 2014-04-23 | 济南新起点医药科技有限公司 | Fermentation preparation method of laying hen feed |
CN104938782A (en) * | 2015-06-19 | 2015-09-30 | 安徽牧翔禽业有限公司 | Feed additive capable of preventing spotted-brown hens from laying soft shell eggs and method for preparing the same |
CN106307551A (en) * | 2016-08-22 | 2017-01-11 | 邵玉华 | Method for preparing organic calcium with eggshells |
-
2018
- 2018-02-28 CN CN201810169527.5A patent/CN108514122A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822691A (en) * | 2009-03-04 | 2010-09-08 | 刘冬妮 | Eggshell calcium |
CN103734507A (en) * | 2013-12-12 | 2014-04-23 | 济南新起点医药科技有限公司 | Fermentation preparation method of laying hen feed |
CN104938782A (en) * | 2015-06-19 | 2015-09-30 | 安徽牧翔禽业有限公司 | Feed additive capable of preventing spotted-brown hens from laying soft shell eggs and method for preparing the same |
CN106307551A (en) * | 2016-08-22 | 2017-01-11 | 邵玉华 | Method for preparing organic calcium with eggshells |
Non-Patent Citations (1)
Title |
---|
王翠菊等: "黄芪多糖对蛋鸡抗氧化性能和蛋品质的影响 ", 《动物营养学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220125093A1 (en) | Nutritional supplements including meal replacements and related methods | |
CN104872504A (en) | Meal-replacing powder capable of replacing daily diet and having balanced nutrition and preparation method of meal-replacing powder | |
CA2606724A1 (en) | Edible film for transmucosal delivery of nutritional supplements | |
CN103238897A (en) | Composite plant solid drink suitable for diabetic patients | |
WO2005123108A2 (en) | Advanced vitamins and protein based nutritional supplements | |
US20040156882A1 (en) | Method and composition for feeding mammals | |
AU2004317895A1 (en) | Dietary supplement and method for treating digestive system-related disorders | |
KR100421466B1 (en) | Manufacturing Method of Absorptive Zinc-Oligopeptide in The Human Body | |
KR20110117685A (en) | A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement | |
JP3433917B2 (en) | Nutritional composition for enhancing body protein accumulation efficiency | |
US20060210606A1 (en) | Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood | |
CN108514122A (en) | The preparation method of minerals supplementing preparation | |
JP4143387B2 (en) | healthy food | |
CN108567139A (en) | A kind of nourishing additive agent for functional beverage | |
CN108208077A (en) | The preparation method of bread nourishing additive agent | |
CN108851037A (en) | A kind of preparation method and its usage of nephrotic syndrome wholefood | |
Brophy et al. | Clinical drug therapy for Canadian practice | |
CN101224005B (en) | Nutrient tablet possessing whole nutrient supplementing efficacy and producing method thereof | |
KR100734944B1 (en) | Functional food-composition with calcium lactate and rice bran | |
CN101415414B (en) | Use of citrulline for preparing drug for treating and correcting arginine lack in sepsis patient | |
Bertz et al. | Principals of Nutrition after Surgical Procedure | |
JP3749647B2 (en) | Blood ammonia reducing agent | |
CN101574369A (en) | Drug composition for reducing blood sugar and blood fat | |
CN109091665A (en) | The preparation and preparation method thereof for preventing pig cartilage disease | |
WO2002096451A1 (en) | Carbohydrate modifying agent and drinks containing the modifying agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180911 |
|
WW01 | Invention patent application withdrawn after publication |